A heterodimeric glucuronide prodrug for cancer tritherapy: the double role of the chemical amplifier. (Q39495340)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

A heterodimeric glucuronide prodrug for cancer tritherapy: the double role of the chemical amplifier (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Marion Grinda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Jonathan Clarhaut

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Isabelle Tranoy-Opalinski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Brigitte Renoux

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Laurent Cronier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sébastien Papot

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

3 August 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

2137-2141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

Prodrug strategies in anticancer chemotherapy

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Enzyme-catalyzed activation of anticancer prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Anticancer prodrugs for application in monotherapy: targeting hypoxia, tumor-associated enzymes, and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Enzymatic activation of second-generation dendritic prodrugs: Conjugation of self-immolative dendrimers with poly(ethylene glycol) via click chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Enhanced cytotoxicity of a polymer-drug conjugate with triple payload of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Dendrimer disassembly by benzyl ether depolymerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Bioactivation of self-immolative dendritic prodrugs by catalytic antibody 38C2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Single-triggered trimeric prodrugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Design of selectively activated anticancer prodrugs: elimination and cyclization strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Design of self-immolative linkers for tumour-activated prodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Beta-glucuronidase-mediated drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Glucuronides in anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

The efficacy of the anthracycline prodrug daunorubicin-GA3 in human ovarian cancer xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Anti-tumour activity and toxicity of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Antiangiogenesis targeting tumor microenvironment synergizes glucuronide prodrug antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

The azaquinone-methide elimination: comparison study of 1,6- and 1,4-eliminations under physiological conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Cure of Mice bearing Advanced Plasma Cell Tumours with Aniline Mustard : the Relationship between Glucuronidase Activity and Tumour Sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

Self-immolative dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

7 January 2021

Single-triggered AB6 self-immolative dendritic amplifiers

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

7 January 2021

“Cascade‐Release Dendrimers” Liberate All End Groups upon a Single Triggering Event in the Dendritic Core

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

7 January 2021

Stereoselective synthesis of (1-alkoxyalkyl) alpha- and beta-D-glucopyranosiduronates (acetal-glucopyranosiduronates): a new approach to specific cytostatics for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

7 January 2021

Distribution and pharmacokinetics of the prodrug daunorubicin-GA3 in nude mice bearing human ovarian cancer xenografts

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

7 January 2021

Prodrugs of anthracyclines for use in antibody-directed enzyme prodrug therapy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

7 January 2021

Protecting groups for glucuronic acid: application to the synthesis of new paclitaxel (taxol) derivatives

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201100355

7 January 2021

Identifiers

DOI

10.1002/CMDC.201100355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21815268%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference